David A. Martin's most recent trade in Titan International, Inc. was a trade of 57,710 Common stock done . Disclosure was reported to the exchange on March 13, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Titan International, Inc. | David A. Martin | SVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2025 | 57,710 | 316,864 (0%) | 0% | 0 | Common stock | |
Titan International, Inc. | David A. Martin | SVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.12 per share. | 13 Mar 2025 | 25,018 | 291,846 (0%) | 0% | 8.1 | 203,271 | Common stock |
Titan International, Inc. | David A. Martin | SVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.08 per share. | 13 Mar 2025 | 7,226 | 284,620 (0%) | 0% | 8.1 | 58,350 | Common stock |
Titan International, Inc. | David A. Martin | SVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2025 | 45,000 | 259,154 (0%) | 0% | 0 | Common stock | |
Titan International, Inc. | David A. Martin | SVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.87 per share. | 10 Mar 2025 | 14,451 | 214,154 (0%) | 0% | 8.9 | 128,180 | Common stock |
Titan International, Inc. | David A. Martin | SVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.39 per share. | 25 Mar 2024 | 5,640 | 228,605 (0%) | 0% | 12.4 | 69,880 | Common stock |
Titan International, Inc. | David A. Martin | SVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.34 per share. | 14 Mar 2024 | 7,050 | 234,245 (0%) | 0% | 12.3 | 86,997 | Common stock |
Titan International, Inc. | David A. Martin | SVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2024 | 45,000 | 249,051 (0%) | 0% | 0 | Common stock | |
Titan International, Inc. | David A. Martin | SVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.86 per share. | 10 Mar 2024 | 7,756 | 241,295 (0%) | 0% | 12.9 | 99,742 | Common stock |
Titan International, Inc. | David A. Martin | SVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.29 per share. | 25 Mar 2023 | 12,691 | 204,051 (0%) | 0% | 10.3 | 130,590 | Common stock |
Titan International, Inc. | David A. Martin | SVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2023 | 50,000 | 216,742 (0%) | 0% | 0 | Common stock | |
Titan International, Inc. | David A. Martin | SVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.57 per share. | 10 Mar 2023 | 7,755 | 166,742 (0%) | 0% | 12.6 | 97,480 | Common stock |
Ocean Biomedical Inc. | Martin David Angle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2023 | 75,000 | 75,000 | - | - | Stock Option (right to buy) | |
Titan International, Inc. | David A. Martin | SVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.39 per share. | 25 Mar 2022 | 12,690 | 174,497 (0%) | 0% | 15.4 | 195,236 | Common stock |
Titan International, Inc. | David A. Martin | SVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2022 | 55,000 | 187,187 (0%) | 0% | 0 | Common stock | |
Titan International, Inc. | David A. Martin | SVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.22 per share. | 14 Jun 2021 | 2,930 | 132,187 (0%) | 0% | 9.2 | 27,015 | Common stock |
Titan International, Inc. | David A. Martin | SVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Mar 2021 | 40,000 | 140,000 (0%) | 0% | 0 | Common stock | |
Titan International, Inc. | David A. Martin | SVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.82 per share. | 25 Mar 2021 | 4,883 | 135,117 (0%) | 0% | 8.8 | 43,044 | Common stock |